CDRH Budget Increase, FDAMA Implementation Among Feigal's Top Priorities
This article was originally published in The Gray Sheet
Executive Summary
David Feigal, MD/MPH, the new director of FDA's Center for Devices and Radiological Health, plans to make the procurement of additional resources for the device center one of his top priorities.
You may also be interested in...
MDUFMA Resource Management Is Schultz’s First Aim As Acting CDRH Chief
Incoming CDRH Acting Director Daniel Schultz, MD, will strive to demonstrate that the center can manage its resources effectively under MDUFMA while meeting statutory performance goals
MDUFMA Resource Management Is Schultz’s First Aim As Acting CDRH Chief
Incoming CDRH Acting Director Daniel Schultz, MD, will strive to demonstrate that the center can manage its resources effectively under MDUFMA while meeting statutory performance goals
Postmarket Surveillance Activity Linked To Device User Fee Proposal
The possibility of medical device user fees eventually funding CDRH postmarket surveillance activity is raised in a provision of the "Medical Device User Fee & Modernizaton Act" of 2002